NurExone Biologic Continues Expansion of U.S. Presence and Awareness with Prestigious Conference Presentation
Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.
Home-care nurses told her not to worry about her bedsore. She was hospitalized the next day
Sylvie Hudon was admitted to the hospital, she says nurses visiting her home told her not to worry about the bedsore located ...
New Jersey Business6d
Kessler Foundation & Overlook First in NJ to Implant Novel Spinal Stimulator
The Tim and Caroline Reynolds Center for Spinal Stimulation at Kessler Foundation has become the first medical center in New ...
GlobalData on MSN6d
Lineage begins study of OPC1 delivering device for spinal cord injury treatment
An allogeneic stem cell-derived transplant, OPC1 helps restore or increase the functional activity in SCI patients. It is tailored to replace the spinal cord cells that are either ...